Overview
- Kuttner announced on November 4 in her podcast that a pending Onko‑test result changed her plan from anti‑hormone treatment plus surgery to neoadjuvant chemotherapy.
- Her medical team told her the test crossed a treatment threshold that indicated higher tumour activity, so they recommended chemotherapy before any operation.
- After the call she had an ultrasound and a small metal marker placed in the tumour and she is scheduled to have a central port inserted this week to receive infusions.
- Chemotherapy will be given weekly on Wednesdays for about 4.5 months, she expects hair loss by Christmas, has obtained a prescription for a wig, and has cancelled in‑person readings and the first part of a 2027 tour.
- Onko‑tests are molecular gene‑expression exams used to assess tumour biology and can change therapy plans by identifying cases where pre‑surgery chemo may better reduce tumour burden before surgery.